Listen to this page using ReadSpeaker

Join Us in Baltimore for VISIONS 2013

VISIONS 2011 Exhibit hallLate June is great for two reasons: the arrival of summer and the annual gathering of Foundation Fighting Blindness members, associates and researchers at its VISIONS conference. This year, VISIONS 2013 will take place in FFB’s founding city, Baltimore, Maryland, June 27-30, and we’ve got it covered.

By that I mean, starting today, Eye on the Cure posts will offer interviews, behind-the-scenes snippets and highlights from research and coping sessions. We’ll also employ social media to cover the event via TwitterFacebook and Instagram. Among those speaking at the conference are blind athlete Craig MacFarlane and Michael Hingson, whose book, Thunder Dog, recounts his escape from the World Trade Center on 9/11 with help from his guide dog.

Both those at VISIONS 2013 and those unable to attend are encouraged to join us on social media to peek at what you may be missing and engage in conversations. And after the conference, on FFB’s YouTube channel, we’ll share videos shot at the VISIONS 2013 video booth, featuring attendees answering questions about their lives and involvement with the Foundation.

The conference will also promote Power of 3, FFB’s annual summer-awareness campaign asking those who take a pledge to fight blindness to follow up with three actions this summer, such as emailing friends, donating money or, if you haven’t already, liking us on Facebook.

VISIONS is always an enlightening, informative and inspiring conference. So we encourage everyone to participate any way they can.

2 Responses to 'Join Us in Baltimore for VISIONS 2013'

  1. Flora Jackson says:

    How can I get into a study of stem cell implants?

    • EyeOnTheCure says:


      Human studies for stem cell therapies are still at very early stages and only for a limited number of people with age-related macular degeneration and Stargardt disease. The primary goal of these studies is to assess safety.

      Here are links to three studies underway in the U.S.:

      ACT’s study for dry AMD:

      Act’s study for Stargardt disease:

      StemCells Inc.’s study for dry AMD

      We recommend that you speak with a doctor who is familiar with retinal degenerations to talk about the pros and cons of clinical trials. If you would like assistance finding an appropriate retinal specialist in your area, contact us at 1-800-683-5555 or

      Also, stay tuned to the blog and the Foundation’s Web site,, for news on forthcoming clinical trials. While you are on the Web site, you can register for our electronic newsletter, which provides news on research advances and clinical trials.

Leave a Reply

Your email address will not be published. Required fields are marked *